Beijing Strong Biotechnologies Secures New Medical Device Registration Certificate

Stock News
Jun 23

Beijing Strong Biotechnologies, Inc. (ASX: 300406) has announced that it recently obtained a Medical Device Registration Certificate issued by the National Medical Products Administration.

The registered product is the Human ABO Blood Group Reverse Typing Erythrocyte Reagent Kit, which is intended for human ABO blood group reverse typing detection. It is for clinical laboratory use only and is not to be used for blood source screening.

The acquisition of this registration certificate enriches the company's product portfolio in the field of in-vitro diagnostics for blood typing.

This development is expected to further enhance the company's core competitiveness and market expansion capabilities, having a positive impact on its future business operations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10